BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31097947)

  • 1. Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma.
    Obata S; Saishin Y; Teramura K; Ohji M
    Case Rep Ophthalmol; 2019; 10(1):67-74. PubMed ID: 31097947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
    Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
    Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy.
    Minami K; Egawa M; Kajita K; Murao F; Mitamura Y
    Case Rep Ophthalmol; 2021; 12(3):952-960. PubMed ID: 35082654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
    Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
    Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review.
    Yilmaz Tugan B; Ozkan B; Sonmez O
    Semin Ophthalmol; 2021 Nov; 36(8):794-799. PubMed ID: 33780309
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
    Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
    Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
    [No Abstract]   [Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report.
    Kikuchi R; Kawagoe T; Hotta K
    BMC Ophthalmol; 2020 Jun; 20(1):252. PubMed ID: 32580711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Nivolumab-Induced Vogt-Koyanagi-Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy.
    Nagai R; Yamamoto A; Yoshida A; Mikawa A
    Case Rep Ophthalmol Med; 2023; 2023():9565205. PubMed ID: 36818144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choroidal excavation in vogt-koyanagi-harada disease.
    Hashida N; Fok A; Nishida K
    Case Rep Ophthalmol; 2014 May; 5(2):222-5. PubMed ID: 25202266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
    Madoe A; Schauwvlieghe PP; Jacob J
    Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
    Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.
    Matsuo T; Yamasaki O
    Clin Case Rep; 2017 May; 5(5):694-700. PubMed ID: 28469878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vogt-Koyanagi-Harada disease in a patient with extreme anisometropia.
    Maehira M; Oshiro A; Imanaga N; Yamauchi Y; Koizumi H
    Am J Ophthalmol Case Rep; 2023 Dec; 32():101929. PubMed ID: 37771387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide-field fluorescein and indocyanine green angiography findings in the eyes with Vogt-Koyanagi-Harada disease.
    Kurobe R; Hirano Y; Niwa N; Sugitani K; Yasukawa T; Yoshida M; Ogura Y
    J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):16. PubMed ID: 28695542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIVOLUMAB-INDUCED HARADA-LIKE UVEITIS WITH BACILLARY DETACHMENT MIMICKING CHOROIDAL METASTASIS.
    Ng CC; Ng JC; Johnson RN; McDonald HR; Agarwal A
    Retin Cases Brief Rep; 2023 May; 17(3):233-238. PubMed ID: 34027908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral uveitis and macular edema induced by Nivolumab: a case report.
    Theillac C; Straub M; Breton AL; Thomas L; Dalle S
    BMC Ophthalmol; 2017 Dec; 17(1):227. PubMed ID: 29195497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma].
    Mihailovic N; Dyballa J; Herz S; Fluck M; Alnawaiseh M; Merté RL; Eter N
    Ophthalmologe; 2020 May; 117(5):467-471. PubMed ID: 31489479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual Case of Vogt-Koyanagi-Harada Disease Associated with SAPHO Syndrome: A Case Report.
    Hasegawa M; Fukutomi A; Jinno A; Fujita K; Kamei M
    Case Rep Ophthalmol; 2018; 9(1):202-208. PubMed ID: 29681837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome.
    Hosseini SM; Dourandish M; Mazouchi M
    J Ophthalmic Vis Res; 2020; 15(1):99-103. PubMed ID: 32128086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular syphilis mimicking Vogt-Koyanagi-Harada disease.
    Lin YC; Lo KJ; Chen SJ; Hwang DK
    Taiwan J Ophthalmol; 2019; 9(4):271-275. PubMed ID: 31942434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.